Introduction: Navigating the SGX Healthcare Landscape for Retail Investors
Singapore’s stock market (SGX) is home to numerous sectors, but the healthcare industry has long been a favorite among retail investors. Known for its defensive nature, healthcare stocks are often seen as stable and resilient in times of market volatility. However, recent earnings results from two key SGX-listed healthcare players — IHH Healthcare and Thomson Medical — have raised questions about the true stability of the sector.
This article will break down the latest earnings results, explore the underlying challenges, and provide insights into how retail investors can assess these healthcare stocks in their portfolios.
IHH Healthcare’s Earnings Decline: What Went Wrong?
Key Financial Highlights for IHH Healthcare (Q2 2025)
- Revenue: RM 6,298 million (+3% YoY)
- Profit Before Tax (PBT): RM 727 million (−19%)
- Net Profit: RM 443 million (−28.9%)
Despite a modest revenue increase, IHH Healthcare reported a significant drop in profitability. The key factors contributing to this decline were higher operational costs, including increased staff expenses, depreciation, and hyperinflationary pressures in Türkiye.
Rising Costs and Inflationary Pressures
IHH’s operations span multiple countries, including Türkiye, where inflation and currency devaluation have exacerbated costs. This highlights the risks of global diversification for investors and underscores the challenges healthcare providers face when managing operational costs across diverse regions.
Thomson Medical Group: Navigating Results Amid Acquisition Risks
Thomson Medical’s Full-Year Earnings Result
- Full-year Net Result: S$47 million (Net Loss)
- H2 Net Result: S$34.7 million (Net Loss)
- Cause: Goodwill impairment linked to its acquisition in Vietnam
Unlike IHH, Thomson Medical reported a full-year earnings result primarily due to a non-cash goodwill impairment. The company’s recent expansion into Vietnam didn’t meet expected returns, leading to this one-off accounting adjustment. However, core operating assets in Singapore and Malaysia remain profitable, which may be a sign of resilience for its local businesses.
Expansion Risks: A Key Learning for Retail Investors
Thomson’s experience underscores the risks involved in overseas acquisitions. While the company’s Singapore-based operations continue to perform well, its international ventures highlight the complexities of integrating foreign markets and managing the risks of overextending into less familiar territories.
What Investors Can Learn from Recent Earnings Results
High Costs in Healthcare: A Common Thread
Both IHH and Thomson Medical face increased operating costs. For healthcare providers, labor costs are a significant part of the operational burden. As demand for skilled professionals rises, retaining talent has become more expensive.
Geopolitical Risks and Currency Exposure
IHH’s exposure to Türkiye’s economic instability serves as a warning about the risks associated with operating in volatile markets. Similarly, Thomson Medical’s international expansion has revealed the potential pitfalls of entering emerging markets with unanticipated challenges.
SGX Healthcare Stocks: Investor Takeaways
The Defensive Healthcare Sector: Not Immune to Risk
While healthcare stocks are often categorized as defensive, it’s important for investors to remember that defensive doesn’t mean risk-free. Rising costs, geopolitical instability, and execution risks in overseas markets can create significant headwinds for even the largest companies in the sector.
Opportunities Amidst Volatility
Despite short-term volatility, both IHH and Thomson remain key players in Asia’s healthcare landscape, with promising long-term growth potential. The ageing population and increasing healthcare demand across the region remain significant drivers for the sector.
Comparing IHH Healthcare & Thomson Medical: Key Differences
| Factor | IHH Healthcare | Thomson Medical |
|---|---|---|
| Scale | Large, global operations | Smaller, regional focus |
| Key Strengths | Strong brand, diversified services | Strong maternity & women’s health |
| Key Risks | Global exposure, inflation | Overseas expansion execution |
| Core Profits | Strong core profits, margin pressure | Profitable local assets |
| Earnings Impact | High costs, currency risks | Goodwill impairment, overseas losses |
What Retail Investors Should Do Next
1. Diversify Within Healthcare
Instead of concentrating on a single healthcare stock, investors should consider a diversified approach within the healthcare sector to mitigate risks. This could include a mix of local market-focused companies and international players.
2. Keep an Eye on Regulatory Changes
Healthcare stocks are highly regulated. Policy changes, particularly in Singapore and other key markets, can significantly impact profitability. Retail investors should stay updated on government policies that affect the healthcare industry.
3. Be Prepared for Short-Term Volatility
Both IHH and Thomson’s recent performance indicate that short-term volatility can be significant, even in the defensive healthcare sector. Retail investors should prepare for potential ups and downs, focusing on long-term trends rather than short-term noise.
Frequently Asked Questions (FAQ)
Q1: What are the main risks of investing in IHH Healthcare and Thomson Medical stocks?
The primary risks include operational cost increases, geopolitical exposure (especially for IHH in Türkiye), and execution risks in overseas acquisitions (particularly for Thomson Medical). Both companies face challenges in managing costs and navigating foreign markets.
Q2: Are healthcare stocks in Singapore a good long-term investment?
Yes, the aging population and increasing demand for healthcare services in Singapore and Asia make healthcare stocks attractive long-term investments. However, like any sector, investors must be mindful of short-term volatility and company-specific risks.
Q3: Should I invest in IHH Healthcare or Thomson Medical after their recent earnings results?
Investing decisions should be based on long-term potential rather than short-term performance. While both companies are facing challenges, they remain leaders in the healthcare sector, and their strong brands and resilient core operations could present opportunities for long-term investors.
Q4: How can I assess the health of a healthcare stock before investing?
Focus on profit margins, cost structure, and geographical diversification. It’s also important to consider regulatory risks and any potential acquisitions or expansions that could impact future performance. Assess the company’s ability to maintain profitability and handle external challenges.
Conclusion: Weighing the Risks and Opportunities in Healthcare Stocks
The recent earnings results from IHH Healthcare and Thomson Medical highlight that the healthcare sector, while promising, is not immune to external and internal pressures. For SGX-listed healthcare stocks, retail investors should remain aware of rising operating costs, geopolitical risks, and expansion challenges. However, the long-term growth potential driven by an ageing population and increasing healthcare demands cannot be overlooked.
Ultimately, diversifying across different healthcare stocks and staying informed about regulatory and economic changes will help mitigate risks while capitalizing on opportunities within this critical sector.